March 21, 2019
Samantha Meltzer-Brody Featured in National News Following FDA Approval of First Postpartum Depression Treatment
UNC participated in three clinical trials for the drug ZULRESSO, developed by Sage Therapeutics. Samantha Meltzer-Brody, MD, MPH, director of the Perinatal Psychiatry Program at the UNC SOM, was the academic principal investigator for the trials, which the FDA reviewed during its approval process for ZULRESSO.